Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red de Apoyo a la Investigación en Hematología y Hemoterapia (RAI-HH) is a specialized clinical research organization based in Spain that facilitates and manages multicenter clinical trials in hematology. Founded by the Spanish Society of Hematology and Hemotherapy (SEHH), RAI-HH provides essential infrastructure for academic and industry-sponsored research, including regulatory affairs, pharmacovigilance, and data management. The organization focuses on advancing treatments for hematological malignancies and non-malignant blood disorders through a network of expert clinicians and hospitals. By streamlining the clinical trial process, RAI-HH plays a pivotal role in bringing innovative therapies, such as CAR-T cells and bispecific antibodies, to patients in Spain. Its services ensure that clinical research conducted within the Spanish hematology community adheres to the highest international quality and ethical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia.